Epic post, mate.

First 35 Last

Share
Profile

Follow
FraserJC

4,274 Posts.

691

03/03/22

13:33

Post #: 59954637
Share

Originally posted by Blackbriar44: ↑

4.2 BILLION Shares. What the hell are these morons thinking and going after a company
that is small and really not enough influence in the U.S. Market and with no real cash making.
There is MUCH consolidation going on in the US market and those being bought is because they are making money
and bought up by MULTI STATE OPERATORS (with a very handsome war chest) because they know these smaller
companies are going to cement their presence.
Now wondering the reasons Bruce was canned by Canopy.
What we are staring at for Cresso is a reduction to a 3 cent stock and then a consolidation of
100 old to one new making it about $3.00 a share.
The fun begins with the whores at the helm begin the capital raises to give themselves
a salary for what they think is a job well done and announce performance shares.
Performance shares for a real pack of Hoodlums while there is no real money making by the company.
(((Boaz and what's her name were the originators of getting money from EverBlu or everblow whatever they call it and
that was the beginning of all the trouble for Cresso.
Blumenthal saw desperation and ran with it.
Another Bernie Madoff plan of destruction.)))
Then the stock begins to settle back to the 3 cent level after all that with management telling us what a great job they are doing.
It will be a bankruptcy with another company coming in to pick up one or two bits and kick the rest to the curb like trash.
GREAT JOB! WELL DONE!!
I have other well meaning TITLES for you bunch but not on these pages.

Expand

Epic post, mate.

CPH Price at posting: 6.1¢ Sentiment: Sell Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 59 more messages in this thread...

First 35 Last

Add CPH (ASX) to my watchlist

Epic post, mate.

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News